Cytomegalovirus Disease in Solid Organ Transplant Recipients
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Disease in Solid Organ Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-04-11FDA Approved: VALGANCICLOVIR — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved the original application for valganciclovir from Florida Pharmaceutical Products, LLC, authorizing the generic drug product for…
-
FDA approval · 2009-08-28FDA Approved: VALCYTE — Original Application (H2-Pharma, LLC)
FDA approved VALCYTE (valganciclovir hydrochloride) under the original application for cytomegalovirus infections, including CMV retinitis i…